The Market Of Recombinant Coagulation Factors Is Growing With Next Generation Products

... The Business Intelligence firm La Merie S.L. reported today that the global market of recombinant coagulation factors VIIa, VIII and IX posted strong 2006 sales of more than US$ 4.6 bln. The still growing market of recombinant coagulation factors has marginated human plasma-derived products. Competition between Baxter, Bayer and Wyeth in the recombinant F. VIII segment (sales of US$ 2. [click link for full article] ...